2. Membrane Transporter/Ion Channel
  3. CFTR
  4. I1421

I1421 is an activator of the cystic fibrosis transmembrane conductance regulator (CFTR) with an EC50 of 64 nM for WT CFTR currents. I1421 also allosterically activates multiple mutants causing cystic fibrosis (CF) with good in vivo potency, with an oral bioavailability of 60% in mice corresponding to a half-life of 75 min. I1421 synergizes with Elexacaftor (HY-111772) to enhance CFTR currents.

For research use only. We do not sell to patients.

I1421 Chemical Structure

I1421 Chemical Structure

Size Price Stock Quantity
5 mg USD 400 Get quote 8 - 10 weeks 8 - 10 weeks 7 - 9 weeks
10 mg USD 650 Get quote 8 - 10 weeks 8 - 10 weeks 7 - 9 weeks
25 mg USD 1310 Get quote 8 - 10 weeks 8 - 10 weeks 7 - 9 weeks
50 mg USD 2100 Get quote 8 - 10 weeks 8 - 10 weeks 7 - 9 weeks
100 mg   Get quote  
200 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

I1421 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Protocol

  • Purity & Documentation

  • References

  • Customer Review

Description

I1421 is an activator of the cystic fibrosis transmembrane conductance regulator (CFTR) with an EC50 of 64 nM for WT CFTR currents. I1421 also allosterically activates multiple mutants causing cystic fibrosis (CF) with good in vivo potency, with an oral bioavailability of 60% in mice corresponding to a half-life of 75 min. I1421 synergizes with Elexacaftor (HY-111772) to enhance CFTR currents[1].

IC50 & Target

EC50: 64 nM (WT CFTR)[1]
In Vivo

I1421 (10 mg/kg; ip, po, sc; single dose) is rapidly absorbed in C57BL/6 mice. After three different administration routes, the maximum plasma concentrations (Cmax) observed 15 min after intraperitoneal and oral administration of 7.4 μM and 3.4 μM, respectively. The plasma level after intraperitoneal administration is higher than that after the other two administration routes[1].
I1421 (3 mg/kg; iv, po; single dose) has a bioavailability of 60% in mice after oral and intravenous injection, but the oral T1/2 is shorter (75 min)[1].

Pharmacokinetic Analysis in C57BL/6 Mice[1]

Route Dose (mg/kg) Tmax (h) Cmax (ng/mL) AUClast (ng·h/mL) T1/2 (h) CL (mL/min/kg) Vss (1/kg) F (%)
IP 10 0.25 2617 2145 2.16 - - -
PO 10 0.25 1181 1211 1.24 - - 60
SC 10 0.50 625 1512 1.36 - - -
IV 3 - 2354 610 1.78 81.51 2.49 -

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Molecular Weight

343.35

Formula

C18H18FN3O3
SMILES

O=C(N1N=C(N)C2=C1C=C(CO)C=C2)[C@@H](C)COC3=CC=C(F)C=C3
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Animal Administration

MCE has not independently confirmed the accuracy of these methods. They are for reference only.
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

I1421 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

I1421I 1421I-1421CFTRCystic fibrosis transmembrane conductance regulatorABC transporteranion channelinhibitorslarge-scale dockingligand discoverypotentiatorsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
I1421
Cat. No.:
HY-158991
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (0 KB) Français - FR (0 KB) Deutsch - DE (0 KB) Norwegian - NO (0 KB) Español - ES (0 KB) Swedish - SV (0 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.